SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desks steep slide to multi-year lows is fueling concern about softer advertising demand and competition from Amazon and other ad-tech platforms. Traders largely criticize management and expect further downside, while some bullish voices see an oversold value opportunity or potential rebound.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, reflecting stronger demand for Amtagvi and Proleukin, is driving a sharp rally. Many traders view the update as validation of the commercial ramp and speculate about short covering, while others flag profit-taking or possible dilution; upcoming lung-cancer data is also a focus.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is under pressure amid fears that Kalshi and Polymarket are taking wagering share and could squeeze sportsbook margins, with regulatory uncertainty around prediction markets adding to sector concerns. Bears see a lasting competitive threat and costly investment, while bulls point to rapid growth in DraftKings own DKeX prediction-market activity and its core sportsbook business.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is plunging after the FHFA moved to include VantageScore alongside FICO in Fannie Mae and Freddie Mac mortgage pricing, raising concerns that competition could erode its scoring businesss longstanding advantage. Traders are split between expecting further pressure on pricing and market share and viewing the selloff as an overreaction, with some buying for a rebound.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly earnings beat and raised full-year outlook, supported by record customer deposits and strong 2027 bookings, drove a sharp rally. Bulls point to resilient cruise demand, while skeptics cite fuel costs, margin pressure and a weaker fourth-quarter earnings outlook.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQures Huntingtons disease gene therapy AMT-130 drew heavy attention after four-year data showed less slowing on the cUHDRS measure than at three years, with the four-year result not statistically significant, prompting a sharp selloff. Traders debate whether this raises concerns about durability or is an overreaction, since the FDA had agreed the BLA could rely on the stronger three-year data; some also question the four-year comparisons external controls and patient dropouts.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Upcoming staggered share unlocks and potential insider selling are the dominant concern, with traders linking the added supply to CBRSs sharp swings and debating whether demand can absorb it. Bullish traders point to Cerebrass AI-inference business and customer partnerships, while others cite broader risk-off conditions and caution about the stocks volatility.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

A Bank of America upgrade and more optimistic outlook are driving Magnites sharp move, with traders welcoming the endorsement and increased volume. Bulls also cite potential benefits from Googles ad-tech remedies, while some caution that past upgrade rallies have faded and debate how quickly those remedies could affect revenue.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyagers newly formalized partnership with Anduril across weapons and propulsion is drawing attention, but shares are falling despite the positive development. Traders are debating whether financing and arbitrage-related overhang is weighing on the stock, while others are frustrated that the partnership has not sparked a stronger reaction.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic investment in Summit and collaboration to study ivonescimab are driving attention, with traders viewing the deal as validation and relief on funding concerns while others focus on dilution and caution that it is not a buyout. The upcoming FDA decision on ivonescimab remains a separate catalyst in the discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$FLTW Upside exists, but only alongside disciplined prioritization and resource control. Margins must remain resilient as activity scales. Momentum stabilizes only when delivery becomes predictable. Proof, rather than potential, becomes the key differentiator.

StockTwits Web

Franklin Templeton ETF Trust - Franklin FTSE Taiwan ETF

 Upside exists, but only alongside disciplined prioritization and resource control. Margins must remain resilient as activity scales. Momentum stabilizes only when delivery becomes predictable. Proof, rather than potential, becomes the key differentiator.